{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:33:13Z","timestamp":1783114393652,"version":"3.54.6"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,4,28]],"date-time":"2012-04-28T00:00:00Z","timestamp":1335571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00415-012-6509-3","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T12:34:41Z","timestamp":1335530081000},"page":"2376-2384","source":"Crossref","is-referenced-by-count":106,"title":["Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany\u2014a nationwide population-based study in children and adults"],"prefix":"10.1007","volume":"259","author":[{"given":"Hajo M.","family":"Hamer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dodel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Strzelczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Balzer-Geldsetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Peter","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Sch\u00f6ffski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Knake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang H.","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Rosenow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Kostev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,28]]},"reference":[{"key":"6509_CR1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eplepsyres.2009.03.002","volume":"85","author":"M Alacqua","year":"2009","unstructured":"Alacqua M, Trifiro G, Spina E, Moretti S, Tari DU, Bramanti P, Caputi AP, Arcoraci V (2009) Newer and older antiepileptic drug use in southern Italy: a population-based study during the years 2003\u20132005. Epilepsy Res 85:107\u2013113","journal-title":"Epilepsy Res"},{"key":"6509_CR2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1528-1167.2007.01007.x","volume":"48","author":"F Andermann","year":"2007","unstructured":"Andermann F, Duh MS, Gosselin A, Paradis PE (2007) Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes. Epilepsia 48:464\u2013469","journal-title":"Epilepsia"},{"key":"6509_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.03.003","volume":"85","author":"PN Banerjee","year":"2009","unstructured":"Banerjee PN, Filippi D, Allen HW (2009) The descriptive epidemiology of epilepsy\u2013a review. Epilepsy Res 85:31\u201345","journal-title":"Epilepsy Res"},{"key":"6509_CR4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/BF01872391","volume":"17","author":"R Banfi","year":"1995","unstructured":"Banfi R, Borselli G, Marinai C, Borgheresi A, Cavalieri A (1995) Epidemiological study of epilepsy by monitoring prescriptions of antiepileptic drugs. Pharm World Sci 17:138\u2013140","journal-title":"Pharm World Sci"},{"key":"6509_CR5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5414\/CPP47617","volume":"47","author":"H Becher","year":"2009","unstructured":"Becher H, Kostev K, Schroder-Bernhardi D (2009) Validity and representativeness of the \u201cDisease Analyzer\u201d patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther 47:617\u2013626","journal-title":"Int J Clin Pharmacol Ther"},{"key":"6509_CR6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.0013-9580.2004.14103.x","volume":"45","author":"E Beghi","year":"2004","unstructured":"Beghi E, Garattini L, Ricci E, Cornago D, Parazzini F (2004) Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS). Epilepsia 45:171\u2013178","journal-title":"Epilepsia"},{"key":"6509_CR7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/0002512-200926020-00007","volume":"26","author":"M Beghi","year":"2009","unstructured":"Beghi M, Savica R, Beghi E, Nobili A, Garattini L (2009) Utilization and costs of antiepileptic drugs in the elderly: still an unsolved issue. Drugs Aging 26:157\u2013168","journal-title":"Drugs Aging"},{"key":"6509_CR8","first-page":"659","volume":"33","author":"I Bielen","year":"2009","unstructured":"Bielen I, Sruk A, Planjar-Prvan M, Cvitanovic-Sojat L, Kosicek M, Bergman-Markovic B, Baraba R, Butkovic-Soldo S (2009) Age-related pattern of the antiepileptic drug utilization in active epilepsy: a population-based survey. Coll Antropol 33:659\u2013663","journal-title":"Coll Antropol"},{"key":"6509_CR9","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1212\/WNL.0b013e3181aa5300","volume":"72","author":"MS Duh","year":"2009","unstructured":"Duh MS, Paradis PE, Latremouille-Viau D, Greenberg PE, Lee SP, Durkin MB, Wan GJ, Rupnow MF, LeLorier J (2009) The risks and costs of multiple-generic substitution of topiramate. Neurology 72:2122\u20132129","journal-title":"Neurology"},{"issue":"Suppl 1","key":"6509_CR10","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1007\/s10198-005-0287-0","volume":"5","author":"M Ekman","year":"2004","unstructured":"Ekman M, Forsgren L (2004) Economic evidence in epilepsy: a review. Eur J Health Econ 5(Suppl 1):S36\u2013S42","journal-title":"Eur J Health Econ"},{"key":"6509_CR11","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/WNL.0b013e3182477edc","volume":"78","author":"E Faught","year":"2012","unstructured":"Faught E, Richman J, Martin R, Funkhouser E, Foushee R, Kratt P, Kim Y, Clements K, Cohen N, Adoboe D, Knowlton R, Pisu M (2012) Incidence and prevalence of epilepsy among older US Medicare beneficiaries. Neurology 78:448\u2013453","journal-title":"Neurology"},{"issue":"Suppl 1","key":"6509_CR12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1468-1331.2005.01191.x","volume":"12","author":"I Forsgren","year":"2005","unstructured":"Forsgren I, Beghi E, Ekman M (2005) Cost of epilepsy in Europe. Eur J Neurol 12(Suppl 1):54\u201358","journal-title":"Eur J Neurol"},{"key":"6509_CR13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1468-1331.2004.00992.x","volume":"12","author":"L Forsgren","year":"2005","unstructured":"Forsgren L, Beghi E, Oun A, Sillanpaa M (2005) The epidemiology of epilepsy in Europe\u2014a systematic review. Eur J Neurol 12:245\u2013253","journal-title":"Eur J Neurol"},{"key":"6509_CR14","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1651-2227.1999.tb01102.x","volume":"88","author":"M Gissler","year":"1999","unstructured":"Gissler M, Jarvelin MR, Louhiala P, Hemminki E (1999) Boys have more health problems in childhood than girls: follow-up of the 1987 Finnish birth cohort. Acta Paediatr 88:310\u2013314","journal-title":"Acta Paediatr"},{"key":"6509_CR15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","volume":"21","author":"A Gustavsson","year":"2011","unstructured":"Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jonsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, den Bergh PV, van OJ, Vos P, Xu W, Wittchen HU, Jonsson B, Olesen J (2011) Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:718\u2013779","journal-title":"Eur Neuropsychopharmacol"},{"key":"6509_CR16","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1111\/j.1528-1167.2006.00889.x","volume":"47","author":"HM Hamer","year":"2006","unstructured":"Hamer HM, Spottke A, Aletsee C, Knake S, Reis J, Strzelczyk A, Oertel WH, Rosenow F, Dodel R (2006) Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany. Epilepsia 47:2165\u20132172","journal-title":"Epilepsia"},{"key":"6509_CR17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(07)70105-9","volume":"6","author":"DC Heaney","year":"2007","unstructured":"Heaney DC, Sander JW (2007) Antiepileptic drugs: generic versus branded treatments. Lancet Neurol 6:465\u2013468","journal-title":"Lancet Neurol"},{"key":"6509_CR18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.yebeh.2010.05.015","volume":"18","author":"SL Helmers","year":"2010","unstructured":"Helmers SL, Paradis PE, Manjunath R, Duh MS, Lafeuille MH, Latremouille-Viau D, Lefebvre P, Labiner DM (2010) Economic burden associated with the use of generic antiepileptic drugs in the United States. Epilepsy Behav 18:437\u2013444","journal-title":"Epilepsy Behav"},{"key":"6509_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dis.2005.8.1","volume":"8","author":"EW Holden","year":"2005","unstructured":"Holden EW, Grossman E, Nguyen HT, Gunter MJ, Grebosky B, Von WA, Nelson L, Robinson S, Thurman DJ (2005) Developing a computer algorithm to identify epilepsy cases in managed care organizations. Dis Manag 8:1\u201314","journal-title":"Dis Manag"},{"key":"6509_CR20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/pds.1871","volume":"19","author":"SA Hollingworth","year":"2010","unstructured":"Hollingworth SA, Eadie MJ (2010) Antiepileptic drugs in Australia: 2002\u20132007. Pharmacoepidemiol Drug Saf 19:82\u201389","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"6509_CR21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eplepsyres.2008.11.018","volume":"84","author":"LP Hsieh","year":"2009","unstructured":"Hsieh LP, Huang CY (2009) Antiepileptic drug utilization in Taiwan: analysis of prescription using National Health Insurance database. Epilepsy Res 84:21\u201327","journal-title":"Epilepsy Res"},{"key":"6509_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2009.07.005","volume":"87","author":"LC Johannessen","year":"2009","unstructured":"Johannessen LC, Larsson PG, Rytter E, Johannessen SI (2009) Antiepileptic drugs in epilepsy and other disorders\u2013a population-based study of prescriptions. Epilepsy Res 87:31\u201339","journal-title":"Epilepsy Res"},{"key":"6509_CR23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2165\/10898530-000000000-00000","volume":"70","author":"AS Kesselheim","year":"2010","unstructured":"Kesselheim AS, Stedman MR, Bubrick EJ, Gagne JJ, Misono AS, Lee JL, Brookhart MA, Avorn J, Shrank WH (2010) Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs 70:605\u2013621","journal-title":"Drugs"},{"key":"6509_CR24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.yebeh.2007.03.014","volume":"11","author":"G Kramer","year":"2007","unstructured":"Kramer G, Biraben A, Carreno M, Guekht A, de Haan GJ, Jedrzejczak J, Josephs D, RK van, Zaccara G (2007) Current approaches to the use of generic antiepileptic drugs. Epilepsy Behav 11:46\u201352","journal-title":"Epilepsy Behav"},{"key":"6509_CR25","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1212\/WNL.0b013e3181df091b","volume":"74","author":"DM Labiner","year":"2010","unstructured":"Labiner DM, Paradis PE, Manjunath R, Duh MS, Lafeuille MH, Latremouille-Viau D, Lefebvre P, Helmers SL (2010) Generic antiepileptic drugs and associated medical resource utilization in the United States. Neurology 74:1566\u20131574","journal-title":"Neurology"},{"key":"6509_CR26","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0895-4356(01)00396-1","volume":"54","author":"AK Mantel-Teeuwisse","year":"2001","unstructured":"Mantel-Teeuwisse AK, Klungel OH, Verschuren WM, Porsius A, BA de (2001) Comparison of different methods to estimate prevalence of drug use by using pharmacy records. J Clin Epidemiol 54:1181\u20131186","journal-title":"J Clin Epidemiol"},{"key":"6509_CR27","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","volume":"369","author":"AG Marson","year":"2007","unstructured":"Marson AG, Al Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR (2007) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369:1000\u20131015","journal-title":"Lancet"},{"key":"6509_CR28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","volume":"369","author":"AG Marson","year":"2007","unstructured":"Marson AG, Al Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR (2007) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369:1016\u20131026","journal-title":"Lancet"},{"key":"6509_CR29","first-page":"335","volume":"102","author":"KS Oles","year":"1987","unstructured":"Oles KS, Gal P, Penry JK, Tapscott WK (1987) Use of antiepileptic drugs in the elderly population. Public Health Rep 102:335\u2013337","journal-title":"Public Health Rep"},{"key":"6509_CR30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1468-1331.2006.01268.x","volume":"13","author":"A Oun","year":"2006","unstructured":"Oun A, Haldre S, Magi M (2006) Use of antiepileptic drugs in Estonia: an epidemiologic study of adult epilepsy. Eur J Neurol 13:465\u2013470","journal-title":"Eur J Neurol"},{"key":"6509_CR31","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1111\/j.1528-1167.2007.01251.x","volume":"48","author":"M Pugliatti","year":"2007","unstructured":"Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P (2007) Estimating the cost of epilepsy in Europe: a review with economic modeling. Epilepsia 48:2224\u20132233","journal-title":"Epilepsia"},{"key":"6509_CR32","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1059-1311(98)80068-X","volume":"7","author":"SJ Roberts","year":"1998","unstructured":"Roberts SJ, Feely M, Bateman DN (1998) Prescribing of anti-epileptic drugs in the northern and Yorkshire region: 1992\u20131995. Seizure 7:127\u2013132","journal-title":"Seizure"},{"key":"6509_CR33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1034\/j.1600-0404.2001.00197.x","volume":"104","author":"P Rochat","year":"2001","unstructured":"Rochat P, Hallas J, Gaist D, Friis ML (2001) Antiepileptic drug utilization: a Danish prescription database analysis. Acta Neurol Scand 104:6\u201311","journal-title":"Acta Neurol Scand"},{"key":"6509_CR34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eplepsyres.2008.05.008","volume":"81","author":"J Sancho","year":"2008","unstructured":"Sancho J, Pena P, Rufo M, Palacios G, Masramon X, Rejas J (2008) Health and non-health care resources use in the management of adult outpatients with drug-resistant epilepsy in Spain: a cost-of-illness study (LINCE study). Epilepsy Res 81:176\u2013187","journal-title":"Epilepsy Res"},{"key":"6509_CR35","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1468-1331.2007.01970.x","volume":"14","author":"R Savica","year":"2007","unstructured":"Savica R, Beghi E, Mazzaglia G, Innocenti F, Brignoli O, Cricelli C, Caputi AP, Musolino R, Spina E, Trifiro G (2007) Prescribing patterns of antiepileptic drugs in Italy: a nationwide population-based study in the years 2000\u20132005. Eur J Neurol 14:1317\u20131321","journal-title":"Eur J Neurol"},{"key":"6509_CR36","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1532-5415.1998.tb06654.x","volume":"46","author":"SC Schachter","year":"1998","unstructured":"Schachter SC, Cramer GW, Thompson GD, Chaponis RJ, Mendelson MA, Lawhorne L (1998) An evaluation of antiepileptic drug therapy in nursing facilities. J Am Geriatr Soc 46:1137\u20131141","journal-title":"J Am Geriatr Soc"},{"key":"6509_CR37","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0895-4356(97)00116-9","volume":"50","author":"DP Shackleton","year":"1997","unstructured":"Shackleton DP, Westendorp RG, Kasteleijn-Nolst Trenite DG, de BA, Herings RM (1997) Dispensing epilepsy medication: a method of determining the frequency of symptomatic individuals with seizures. J Clin Epidemiol 50:1061\u20131068","journal-title":"J Clin Epidemiol"},{"key":"6509_CR38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00019053-200826060-00002","volume":"26","author":"A Strzelczyk","year":"2008","unstructured":"Strzelczyk A, Reese JP, Dodel R, Hamer HM (2008) Cost of epilepsy: a systematic review. Pharmacoeconomics 26:463\u2013476","journal-title":"Pharmacoeconomics"},{"key":"6509_CR39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0920-1211(02)00013-X","volume":"48","author":"A Tetto","year":"2002","unstructured":"Tetto A, Manzoni P, Millul A, Beghi E, Garattini L, Tartara A, Avanzini G (2002) The costs of epilepsy in Italy: a prospective cost-of-illness study in referral patients with disease of different severity. Epilepsy Res 48:207\u2013216","journal-title":"Epilepsy Res"},{"key":"6509_CR40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1600-0404.2006.00639.x","volume":"113","author":"I Tsiropoulos","year":"2006","unstructured":"Tsiropoulos I, Gichangi A, Andersen M, Bjerrum L, Gaist D, Hallas J (2006) Trends in utilization of antiepileptic drugs in Denmark. Acta Neurol Scand 113:405\u2013411","journal-title":"Acta Neurol Scand"},{"key":"6509_CR41","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00228-008-0480-z","volume":"64","author":"NW Vrie-Hoekstra van de","year":"2008","unstructured":"van de Vrie-Hoekstra NW, de Vries TW, van den Berg PB, Brouwer OF, de Jong-van den Berg LT (2008) Antiepileptic drug utilization in children from 1997 to 2005\u2013a study from the Netherlands. Eur J Clin Pharmacol 64:1013\u20131020","journal-title":"Eur J Clin Pharmacol"},{"key":"6509_CR42","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1528-1157.2000.tb00246.x","volume":"41","author":"PE Waaler","year":"2000","unstructured":"Waaler PE, Blom BH, Skeidsvoll H, Mykletun A (2000) Prevalence, classification, and severity of epilepsy in children in western Norway. Epilepsia 41:802\u2013810","journal-title":"Epilepsia"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6509-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-012-6509-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6509-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T23:54:40Z","timestamp":1713916480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-012-6509-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,28]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["6509"],"URL":"https:\/\/doi.org\/10.1007\/s00415-012-6509-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,28]]}}}